Oxford

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Huntington's disease1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Alnylam Pharmaceuticals1 trial
• Syndax Pharmaceuticals1 trial

Running trials

• Recruiting

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· Phase 3· Syndax Pharmaceuticals· Source

  Contact: Syndax Pharmaceuticals

• Recruiting

  A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease

  NCT06585449· Phase 1· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Childhood cancers1 recruiting
• Huntington's disease1 recruiting